CD38, an ectoenzyme, locates on the surface of a variety of immune cells. It is also in other cellular parts, such as the mitochondria. Soluble CD38 is present in cytoplasm. It’s part of the extracellular CD38/CD203a/CD73/CD39 pathway to modulate adenosine production. CD38 is one of the first pathway steps, producing ADPR from NAD+.
Extracellular adenosine is a key player in the regulation of inflammation and immunogenicity. As such CD38 provides a potential target for tumor evasion and inflammatory-related disease. Intracellular CD38 is also a target for asthma as cADPR-mediates calcium channels that control smooth muscle associated with breathing.
The Transcreener CD38 Assay Service is an excellent tool for researchers examining the therapeutic effects of CD38.